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Pyrazine is an attractive molecule that has been incorporated as a bridging ligand between 
two metal centres. These complexes have been shown to exhibit both magnetic and 
electrochemical exchange between the metal centres through the pyrazine unit. Addition 
of functionality onto the 2 and 5 position of pyrazine can reinforce the coordination of 3d 
octahedral metal ions to the pyrazine ring.  
The Schiff base condensation of A1 with various primary amine reactants produced three 
unique ligand systems. The confirmed synthesis of these ligands was verified with a 
variety of characterisation techniques. A single crystal structure was generated for one 
ligand system (L3), which revealed both imine – π stacking interactions, as well as alkane 
hydrogen – pyridine interactions.  
Several complexations were attempted with the three ligand systems synthesised. 
Manganese and cobalt complexes were successfully synthesised with L3, the single 
crystal structures generated showed cyclohelicate triangles, which were unique at the 
time. The electrochemical analysis of these complexes in MeCN showed similar redox 
processes as was seen in the electrochemical analysis of L3. Signs of possible metal-metal 
communication within the cyclohelicate triangles was also noticed, with oxidation (and 
reduction) processes present. Further analysis is necessary to verify these interpretations, 
including magnetic analysis. Complexations with identical metal salts and L2 could not 
be characterised by SCXRD Other techniques such as mass spectrometry and 
conductivity measurements indicated the likely formation of a polymorphic – potentially 
cyclohelical structure with this ligand. Complexations with L1 incorporated the inclusion 
of a larger collection of metal salts. Unfortunately, due to time constraints, only three 
complexes were suitably characterised. From the various characterisation methods used, 
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it was deduced that all three complexes were likely simple M2L1 systems, where the 
coordination of the 6-coordinate 3d metal centres were accompanied by the coordination 
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